Clinical trial NCT05601479 - References

Chemotherapy-induced Peripheral Neuropathy — Preventive Effect of Acetyl-L-carnitine on Oxaliplatin-induced Peripheral Neuropathy

Citation(s)

•   Campone M, Berton-Rigaud D, Joly-Lobbedez F, Baurain JF, Rolland F, Stenzl A, Fabbro M, van Dijk M, Pinkert J, Schmelter T, de Bont N, Pautier P
  A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the pr
•   Hershman DL, Unger JM, Crew KD, Minasian LM, Awad D, Moinpour CM, Hansen L, Lew DL, Greenlee H, Fehrenbacher L, Wade JL 3rd, Wong SF, Hortobagyi GN, Meyskens FL, Albain KS
  Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the pre
•   Sun Y, Shu Y, Liu B, Liu P, Wu C, Zheng R, Zhang X, Zhuang Z, Deng Y, Zheng L, Xu Q, Jiang B, Ouyang X, Gao J, Xu N, Li X, Jiang S, Liang C, Yao Y
  A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of che

Preventive Effect of Acetyl-L-carnitine on Oxaliplatin-induced Peripheral Neuropathy： A Randomized, Controlled, Open-label, Phase 2 Trail

Details for clinical trial NCT05601479